These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

605 related items for PubMed ID: 31654558

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Transcranial doppler quantification of residual shunt after percutaneous patent foramen ovale closure: efficacy of the GORE(®) HELEX septal occluder.
    Sorensen SG, Smout R, Spruance SL.
    J Interv Cardiol; 2011 Aug; 24(4):366-72. PubMed ID: 21492220
    [Abstract] [Full Text] [Related]

  • 25. Safety and performance of the Spider™ patent foramen ovale occluder.
    Edwards-Lehr T, Franke J, Bertog SC, Bäcker C, Wunderlich N, Hofmann I, Wilson N, Piechaud JF, Sievert H.
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):317-23. PubMed ID: 22887130
    [Abstract] [Full Text] [Related]

  • 26. Closure of patent foramen ovale defects using GORE® CARDIOFORM septal occluder: Results from a prospective European multicenter study.
    Hardt SE, Eicken A, Berger F, Schubert S, Carminati M, Butera G, Grohmann J, Höhn R, Nielsen-Kudsk JE, Hildick-Smith D, Settergren M, Thomson JD, Geis N, Søndergaard L.
    Catheter Cardiovasc Interv; 2017 Nov 01; 90(5):824-829. PubMed ID: 28296023
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Transcatheter Closure of Patent Foramen Ovale: Devices and Technique.
    Price MJ.
    Interv Cardiol Clin; 2017 Oct 01; 6(4):555-567. PubMed ID: 28886846
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Second transcatheter closure for residual shunt following percutaneous closure of patent foramen ovale.
    Susuri N, Obeid S, Ulmi M, Siontis GCM, Wahl A, Windecker S, Nietlispach F, Meier B, Praz F.
    EuroIntervention; 2017 Sep 20; 13(7):858-866. PubMed ID: 28437244
    [Abstract] [Full Text] [Related]

  • 32. Device-related risk of atrial fibrillation after closure of patent foramen ovale: a systematic review and meta-analysis.
    Vukadinović D, Scheller B, Ukena C, Ewen S, Mahfoud F, Böhm M.
    Clin Res Cardiol; 2022 May 20; 111(5):583-587. PubMed ID: 34757488
    [Abstract] [Full Text] [Related]

  • 33. Post-Market Clinical Follow-Up With the Patent Foramen Ovale Closure Device IrisFIT (Lifetech) in Patients With Stroke, Transient Ischemic Attack, or Other Thromboembolic Events.
    Sievert K, Yu J, Bertog S, Hornung M, von Bardeleben RS, Gafoor S, Reinartz M, Matic P, Hofmann I, Grunwald I, Schnelle N, Sievert H.
    Cardiovasc Revasc Med; 2021 Sep 20; 30():72-75. PubMed ID: 33097460
    [Abstract] [Full Text] [Related]

  • 34. Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud® in patients with stroke or transient ischemic attack.
    Steinberg DH, Bertog SC, Momberger J, Franke J, Hofmann I, Renkhoff K, Joy S, Vaskelyte L, Sievert H.
    Catheter Cardiovasc Interv; 2015 Jun 20; 85(7):1262-7. PubMed ID: 24948394
    [Abstract] [Full Text] [Related]

  • 35. Patent foramen ovale closure in children without cardiopathy: Child-PFO study.
    Miton N, Godart F, Milani G, Jalal Z, Karsenty C, Baruteau AE, Gronier C, Aldebert P, Douchin S, Lucron H, Chalard A, Houeijeh A, Petit J, Hascoet S, Thambo JB, Dauphin C.
    Arch Cardiovasc Dis; 2020 Jun 20; 113(8-9):513-524. PubMed ID: 32680737
    [Abstract] [Full Text] [Related]

  • 36. Efficacy of different devices for transcatheter closure of patent foramen ovale assessed by serial transoesophageal echocardiography and rates of recurrent cerebrovascular events in a long-term follow-up.
    Luani B, Markovic S, Krumsdorf U, Rottbauer W, Wöhrle J.
    EuroIntervention; 2015 May 20; 11(1):85-91. PubMed ID: 25572024
    [Abstract] [Full Text] [Related]

  • 37. Amplatzer or Figulla Flex II Occluder: a comparative study of outcomes after transcatheter patent foramen ovale closure.
    Toggweiler S, Moccetti F, Conrad N, Loretz L, Madanchi M, Bossard M, Attiger-Toller A, Cuculi F, Wolfrum M.
    J Invasive Cardiol; 2024 Apr 20; 36(4):. PubMed ID: 38412438
    [Abstract] [Full Text] [Related]

  • 38. Risk and fate of residual interatrial shunting after transcatheter closure of patent foramen ovale: a long term follow up study.
    Hammerstingl C, Bauriedel B, Stüsser C, Momcilovic D, Tuleta I, Nickenig G, Skowasch D.
    Eur J Med Res; 2011 Jan 27; 16(1):13-9. PubMed ID: 21345765
    [Abstract] [Full Text] [Related]

  • 39. Percutaneous closure of inter-atrial communications (atrial septal defect and patent foramen ovale): single-centre experience and mid-term follow-up.
    Van de Bruaene A, Stroobants D, Benit E.
    Acta Cardiol; 2015 Apr 27; 70(2):133-40. PubMed ID: 26148372
    [Abstract] [Full Text] [Related]

  • 40. Transcatheter Closure of Atrial Septal Defect: A Review of Currently Used Devices.
    Shrivastava S, Shrivastava S, Allu SVV, Schmidt P.
    Cureus; 2023 Jun 27; 15(6):e40132. PubMed ID: 37425612
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.